ZA816085B - New analogues of insulin - Google Patents

New analogues of insulin

Info

Publication number
ZA816085B
ZA816085B ZA816085A ZA816085A ZA816085B ZA 816085 B ZA816085 B ZA 816085B ZA 816085 A ZA816085 A ZA 816085A ZA 816085 A ZA816085 A ZA 816085A ZA 816085 B ZA816085 B ZA 816085B
Authority
ZA
South Africa
Prior art keywords
insulin
des
denotes
ala
thr
Prior art date
Application number
ZA816085A
Inventor
Rolf Geiger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA816085B publication Critical patent/ZA816085B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

1. Claims for Contracting States : BE, LI, DE, FR, GB, IT, NL, SE Insulin of the formula I see diagramm : EP0046979,P10,F1 in which X denotes Thr or OH and Y denotes Asp or Asn. 1. Claims for Contracting States : AT A process for the preparation of an insulin of the formula I, see diagramm : EP0046979,P12,F1 in which X denotes Thr or OH and Y denotes Asp or Asn, which comprises a) converting human insulin, desamido**A21 -human insulin, des-Thr**B30 -human insulin, desamido**A21 -des-Thr**B30 -human insulin, des-Ala**B30 -swine insulin or desamido**A21 - des-Ala**B30 swine insulin into the N**alpha AI -N**vepsiln B29 -bis-Boc compound and subjecting this to Edman degradation, b) treating des-Phe**BI -human insulin or des-Phe**BI -des-Ala**B20 -swine insulin with acid, or c) treating a compound of the formula I in which X denotes Ala with carboxypeptidase A.
ZA816085A 1980-09-03 1981-09-02 New analogues of insulin ZA816085B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803033127 DE3033127A1 (en) 1980-09-03 1980-09-03 NEW INSULIN ANALOG

Publications (1)

Publication Number Publication Date
ZA816085B true ZA816085B (en) 1982-08-25

Family

ID=6111025

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA816085A ZA816085B (en) 1980-09-03 1981-09-02 New analogues of insulin

Country Status (9)

Country Link
EP (1) EP0046979B1 (en)
JP (1) JPS5777655A (en)
AT (1) ATE4591T1 (en)
AU (1) AU545399B2 (en)
CA (1) CA1173388A (en)
DE (2) DE3033127A1 (en)
DK (1) DK149778C (en)
ES (1) ES505039A0 (en)
ZA (1) ZA816085B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3327928A1 (en) * 1983-08-03 1985-02-21 Hoechst Ag, 6230 Frankfurt METHOD FOR PRODUCING INSULIN DERIVATIVES
DE3333640A1 (en) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt METHOD FOR THE PRODUCTION OF INSULIN DERIVATIVES, THE B-CHAIN C-TERMINAL EXTENDED, NEW BASICALLY MODIFIED INSULIN DERIVATIVES, THE MEANS CONTAINING THEM AND THEIR USE
DK347086D0 (en) * 1986-07-21 1986-07-21 Novo Industri As NOVEL PEPTIDES
DE3837825A1 (en) * 1988-11-08 1990-05-10 Hoechst Ag NEW INSULIN DERIVATIVES, THEIR USE AND A PHARMACEUTICAL PREPARATION CONTAINING THEM
CN1125081C (en) * 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 Recombined natural and new-type human insulin and its preparation
DE10114178A1 (en) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinc-free and low-zinc insulin preparations with improved stability
DE10227232A1 (en) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Sour insulin preparations with improved stability
HUE037449T2 (en) 2008-10-17 2018-08-28 Sanofi Aventis Deutschland Combination of an insulin and a glp-1 agonist
AR080669A1 (en) 2009-11-13 2012-05-02 Sanofi Aventis Deutschland PHARMACEUTICAL COMPOSITION INCLUDING A GLP-1 AGONIST, AN INSULIN AND METIONIN
WO2011058082A1 (en) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a glp-1 agonist and methionine
ES2606554T3 (en) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Use of AVE0010 for the manufacture of a medication for the treatment of type 2 diabetes mellitus
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
BR112014004726A2 (en) 2011-08-29 2017-04-04 Sanofi Aventis Deutschland pharmaceutical combination for use in glycemic control in type 2 diabetes patients
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
PL3229828T3 (en) 2014-12-12 2023-07-31 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (en) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 Treatment type 2 diabetes mellitus patients
TW201705975A (en) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 Treatment of type 2 diabetes mellitus patients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364116A (en) * 1964-11-02 1968-01-16 Squibb & Sons Inc Method of use of desalanino insulin compositions
DE2256215C3 (en) * 1972-11-16 1981-01-08 Hoechst Ag, 6000 Frankfurt Insulin preparation containing crystalline insulin and amorphous desphenylalanine8 '-insulin

Also Published As

Publication number Publication date
DK149778C (en) 1987-04-06
DE3033127A1 (en) 1982-04-08
CA1173388A (en) 1984-08-28
AU7488381A (en) 1982-03-11
DE3160852D1 (en) 1983-10-13
ATE4591T1 (en) 1983-09-15
ES8206448A1 (en) 1982-08-16
ES505039A0 (en) 1982-08-16
DK149778B (en) 1986-09-29
AU545399B2 (en) 1985-07-11
EP0046979B1 (en) 1983-09-07
JPS5777655A (en) 1982-05-15
EP0046979A1 (en) 1982-03-10
DK388081A (en) 1982-03-04

Similar Documents

Publication Publication Date Title
DE3160852D1 (en) Insulin analogues
HUT39046A (en) Method for converting harvester from operating position, when the longitudinal axle of machine-body is transversal to the direction of work, into transport position, when the logitudinal axle of machine-body is parallel to the direction of work and harvesters using this method
GB2090585B (en) Plant treating compositions comprising titanium-ascorbic acid chelate
PT85950A (en) Process for the preparation of protamine zinc insulin compositions useful for treating diabetes
JPS5756452A (en) N-phenylsulfonyl-n'-pyrimidinyl- and -triazinylurea, manufacture and plant growth regulant composition
IL57991A (en) Propargyloximino-trimethylbicyclo(2,2,1)heptane,its preparation and plant growth regulating and insecticidal compositions containing it
JPS54163812A (en) Substituted benzorylthioalkanoic acid as plant growth regulating agent
LU81578A1 (en) 1,2,3-TRIAZOLE-CARBONIC ACID AMIDES, METHOD FOR PRODUCING THESE COMPOUNDS AND THE BIOCIDES CONTAINING THEM
IL63211A0 (en) 1-aryl-cyclopropane-1-carboxylic acid esters,their preparation and their use as pesticides
IL64309A0 (en) 2'-phenylhydrazino-2-cyano acrylic acid esters,their manufacture and their use as herbicides
PT70124A (en) N,n-dimethyl-carbamic acid o-pyrimidinyl esters process for their preparation and their use as agents for combating pests
NZ214107A (en) Method of increasing the ovulation rate or fecundity of sows by use of an immunogenic composition
GB2091999B (en) Composition for treatment of psoriasis containing 10-substituted 1,8-dihydroxy-9-anthrones
HUT38321A (en) Herbicide compositions containing substituted carboxylic acid anilides as active substances and process for preparing the active substances
JPS5567361A (en) Encircling body for treating portion material to be worked
IL66193A0 (en) S-azolylmethyl-di-(and-tri-)-thiophosphoric acid esters,their preparation and their use as pesticides
AU6461590A (en)
JPS5413590A (en) Improvement in adhesiveness of synthetic fiber material for reinforcing elastomers
JPS5675458A (en) Fluorineesubstituted 2*2*3*33tetramethyll cyclopropanee11carboxylic acid benzylester* its manufacture and noxious organism repellant composition containing it
DE3568273D1 (en) Trichloroacetortoxy-3,4,5,6-tetrachlorobenzoic acid chemoterapeutically active against cutaneous and subcutaneous benigne neoformations, process for its preparation and compositions conmtaining the same
JPS55139374A (en) 55*22hydroxyy33thiopropoxy*chromonee22carboxylic acid*its manufacture and medical composition
DE2860733D1 (en) (1,2,3,4,5,6h)-triazine-2,4-diones, method for their preparation and their use as insecticides
IL65107A (en) 2,2-dimethyl-3-alkenyl-cyclopropanecarboxylic acid esters of 3-(alkenyl-and alkynylphenoxy)benzyl alcohols,their production and their use as pesticides
GB2023578B (en) Method for the preparation o 2--phenylacetic acid and intermediate for use therein
MN173A6 (en) Triethanolamine salt of 2,4-chlorophenoxycetic acid as biological stimulant